| ADE | acute disseminated encephalitis; adverse drug event; antibody-dependent enhancement; apparent digest... |
|---|---|
| AE | above-elbow [amputation]; acrodermatitis enteropathica; activation energy; adult erythrocyte; advers... |
| PEM | pediatric emergency medicine; peritoneal exudate macrophage; polymorphic epithelial mucin; prescript... |
| AD | accident dispensary; acetate dialysis; active disease; acute dermatomyositis; addict, addiction; ade... |
| CPD | calcium pyrophosphate deposition; cephalopelvic disproportion; cerebelloparenchymal disorder; childh... |
| CARD | Catalysed Reporter Deposition |
|---|---|
| LCDD | K-light chain deposition disease |
| ADE | Adverse Drug Event |
| ALTE | Apparent Life Threatening Event |
| AERP | Auditory Event-Related Potentials |
energetics
| calcium pyrophosphate deposition disease | <radiology> Manifestations can occur singly or in any combination, pseudogout, acute crystal-induced synovitis with clinical symptoms analogous to gout, arthropathy, beaklike osteophytes of 2nd, 3rd metacarpal heads, subchondral cysts (especially carpal bones), unusual distribution of disease (radiocarpal/ulnar joint, patellofemoral joint), SLAC - scapholunate advanced collapse, chondrocalcinosis, triangular fibrocartilage, symphysis pubis, menisci of knee, annulus fibrosus of intervertebral disk (12 Dec 1998) |
|---|---|
| tamm-horsfall protein deposition | <radiology> Also known as stasis nephropathy, perinatal renal insult of less severe degree than acute cortical necrosis, prolonged nephograms on IV urograms, renal ultrasound: increased echogenicity in central portions of pyramids, preservation of hypoechoic peripheral medulla, due to deposition of Tamm-Horsfall protein in the tubules, Benign course, usually resolves completely Stephen H. Hite, M.D. (12 Dec 1998) |
| adverse event | A toxic reaction to a medical therapy. (09 Oct 1997) |
| vertical displacement event | Disruption which occurs because plasma is not adequately stabilised against vertical motions. (09 Oct 1997) |
| event, adverse | In pharmacology, an adverse event is any unexpected or dangerous reaction to a drug. (12 Dec 1998) |
| event-related potentials, p300 | A late-appearing component of the event-related potential. P stands for positive voltage potential and 300 represents 300 millisecond poststimulus. Its amplitude increases with unpredictable, unlikely, or highly significant stimuli and thereby constitutes an index of mental activity. (12 Dec 1998) |
| activation energy | <chemistry> The amount of energy (expressed in joules) that is needed to convert all the molecules in one mole of a reacting substance from a ground state to the transition state. (06 May 1997) |
| binding energy | <chemistry, radiobiology> The binding energy of a nucleus is the minimum energy required to dissociate it into its component neutrons and protons. Neutron or proton binding energies are those required to remove a neutron or proton, respectively, from a nucleus. Electron binding energy is that required to remove an electron from an atom or a molecule. (16 Dec 1997) |
| bioelectric energy sources | Implantable devices which convert biological energy (chemical energy of the metabolism of continuously regenerating body fluids or mechanical energy of periodic movements) to electrical energy. The sources include biogalvanic cells, biofuel cells, and ionic concentration cells. (12 Dec 1998) |
| biomass energy | See Bioenergy. (05 Dec 1998) |
| bond dissociation energy | This is the energy needed to break the bonds between two linked atoms. (09 Oct 1997) |
| bond energy | The energy needed to break a molecular bond. (09 Oct 1997) |
| radiant energy | Energy contained in light rays or any other form of radiation. (05 Mar 2000) |
| radiography, dual-energy scanned projection | A method of producing a high-quality scan by digitizing and subtracting the images produced by high- and low-energy X-rays. (12 Dec 1998) |
| radiotherapy, high-energy | Radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; X-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|